Absent or reversed end diastolic flow (AREDF) velocities in the umbilical artery were identified in 25 high risk pregnancies. In six pregnancies the fetus was abnormal and all but one of these ended in perinatal death. Of the 19 morphologicaily normal fetuses, three died in utero and there were four neonatal or infant deaths. The mortality rate was 48% for ali pregnancies and 37% for those with morphologicaily normal fetuses. There was a highly significant increased risk for the development of necrotising enterocolitis in those morphologicaily normal fetuses with AREDF (53%) compared with controls (6%) who did have umbilical artery end diastolic flow velocities in fetal life. There were no significant differences between the matched pairs for parameters of neonatal outcome chosen to reflect neonatal morbidity. These findings demonstrate the close association between AREDF and necrotising enterocolitis that appears to be independent of other variables such as degree of growth retardation, prematurity, and perinatal asphyxia.
Doppler ultrasound technology has made it possible to study the flow characteristics of the fetal circulation.' Over the past decade many data have been reported which link abnormal umbilical artery flow velocity waveforms with growth retardation and perinatal asphyxia.2 3 However, the exact role for such measurements in the management of high risk pregnancy remains unclear. 4 Recent reports have suggested an association between very abnormal umbilical artery and fetal aorta Doppler studies showing absent or reversed end diastolic flow (AREDF) velocities and severe neonatal morbidity including necrotising enterocolitis.5 6 This may simply reflect the fact that very growth retarded, preterm fetuses are more likely to demonstrate AREDF and will often develop necrotising enterocolitis. This paired analysis study was designed to test the hypothesis that it is AREDF, independent of growth retardation and prematurity, which predisposes to necrotising enterocolitis.
Methods
Over a three year period (April 1987 to April 1990) over 1000 high risk pregnancies were monitored by the recording of flow velocity waveforms from the umbilical artery. All fetuses were studied using a GE RT3600 ultrasound system with pulsed Doppler. Waveforms were obtained using a 5 MHz phased array sector transducer, and a 100 Hz wall filter was used. In each study waveforms were continuously displayed until an optimum signal was obtained and then five consecutive waveforms selected for analysis. Waveforms were analysed for both maximum systolic:minimum diastolic ratio (A:B ratio) and pulsatility index.7 The results of Doppler studies were not revealed to obstetricians or neonatologists involved in the management of these pregnancies. The study was approved by the hospital ethics committee and all patients gave informed consent.
From these pregnancies 25 cases were identified in which there was AREDF in the umbilical artery. Liveborn fetuses without congenital malformations were subjected to analysis of parameters of neonatal outcome. One neonate who survived two hours only was excluded from further analysis. These neonates were matched for gestational age and birth weight with neonates in whom Doppler studies had consistently shown end diastolic flow in the umbilical artery before delivery. Controls were drawn from the nursery population during the same time period as the cases and were chosen for best fit for both birth weight and gestational age.
For the matched pairs the following were analysed as dichotomous variables:
( Necrotising enterocolitis was classified as none, suspect, or proved. The suspect group had the clinical features of necrotising enterocolitis (that is, abdominal distension, bile aspirates or vomiting, blood in the stools, and systemic illness) and were treated with parenteral nutrition and antibiotics. Proved cases had in addition the radiological features of pneumatosis coli, perforation, or gas in the portal circulation. Laparotomy or necropsy evidence was also classified as proved necrotising enterocolitis.
Neonatal radiographs and ultrasound scans were reviewed by a paediatric radiologist without knowledge of the clinical history. All the neonates less than 32 weeks' gestation, all ventilated neonates, and all those with abnormal neurological signs received routine cranial ultrasound examinations in this nursery. The num- 
Results
During this period 25 pregnancies were identified in which fetuses showed AREDF. The pregnancies were complicated by hypertension (n= 11), obstetric lupus syndrome (n= 3), unexplained growth retardation (n=3), renal failure (n =1), twins (n= 1), and congenital malformations (n=6). Those with congenital malformations have been excluded from further analysis. Of the 19 morphologically normal fetuses three died in utero and one died within 24 hours of birth, leaving 15 neonates (the cases) to be matched with controls. The overall mortality in fetuses with AREDF was 48% (12/25). Excluding congenital malformations the mortality was 37% (7/19). The three neonates from the case group of 15 who died did so at 42, 180, and 190 days respectively. The causes of death were complications of fulminating necrotising enterocolitis in the first of these and chronic lung disease in the second and third. There were no deaths in the control group.
MATCHED PAIRS
The gestational age at delivery ranged from 26- 35 weeks (mean (SD) 30 5 (2-95) weeks) for the cases and 26-34 weeks (mean (SD) 30 4 (2-85) weeks) for the control group. The birth weight ranged from 504-1635 g (mean (SD) 1059 (343) g) in the cases and 515-1748 g (mean (SD) 1079 (353) g in the control group. There were no significant differences between the cases and controls for birth weight (p=085) or gestational age (p=082) by Wilcoxon rank sum test. There were eight boys and seven girls in the cases and four boys and 11 girls in the control group.
The characteristics of the matched pairs are shown in table 1. Table 2 shows the incidence of proved or suspect necrotising enterocolitis in the two groups. There is a highly significant increase in the incidence of necrotising enterocolitis in neonates who demonstrated AREDF (x2=5-14, df 1, 005>p>0 01 by McNemar's test).
When matched pairs were examined for the presence of asphyxia there were five discordant pairs but in four of these the direction was towards the control. Similarly for respiratory distress there were six discordant pairs with the direction being towards the control in five. There were no significant differences between the matched pairs for days of ventilation (p=0-62) and maximum oxygen concentration (p=0-27) by the Wilcoxon rank sum test. AREDF could also be used in case finding for prospective, controlled trials of necrotising enterocolitis prevention or treatment. Obstetricians should also be aware of the high incidence of fetal abnormality in the growth retarded fetus with AREDF.
We would like to thank Dr J Anderson and Dr A Boogert for allowing us to study their patients. We also thank Ms Deborah Edwards for statistical advice.
enterocolitis.
in the umbilical artery and necrotising Absent or reversed end diastolic flow velocity
